Immunovant, Inc. IMVT United States — Total loss before income taxes

Other geography segments

Similar metrics at other companies

SUNUNITED STATES — Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax

$99.25M-61.8%

SSRMUnited States — Income (loss) before income and mining taxes

$120.38M+354%

GMEUnited States — Operating income (loss)

$144.6M+330%

INCYUnited States — Income before provision for income taxes

$392.94M+291%

ZTSU.S. — Income before provision for taxes on income

$697M-10.5%

EWUnited States — Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest

$610.7M+9.2%

Questions, answered.

What is Immunovant, Inc.'s united states — total loss before income taxes?

Immunovant, Inc. (IMVT) reported united states — total loss before income taxes of $25.25M in Q1 2026.

How has Immunovant, Inc.'s united states — total loss before income taxes changed year-over-year?

Immunovant, Inc.'s united states — total loss before income taxes increased by 669.6% year-over-year, from -$4.43M to $25.25M.

What is the long-term trend for Immunovant, Inc.'s united states — total loss before income taxes?

Over 4 years (2022 to 2026), Immunovant, Inc.'s united states — total loss before income taxes has grown at a 23.1% compound annual growth rate (CAGR), from -$43.95M to $100.99M.

What does united states — total loss before income taxes mean?

Represents the total pre-tax financial loss generated by operations within the United States geographic segment. This metric highlights the profitability profile of the company's domestic activities before accounting for income tax expenses or benefits. It is a key indicator of the underlying operational performance of the domestic business unit.